SCHEMBL6750159

SCHEMBL6750159

CCOC(=O)C=CC1CCNCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.44
L3MBTL1 Q9Y468 3/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
MAPT P10636 2/20 0.38
TTR P02766 1/20 0.36
DPP4 P27487 1/20 0.36
ESR2 Q92731 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CYP3A4 P08684 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
ALDH1A1 P00352 1/20 0.34
PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6750154 1.00 HCAR2 (0.44) HCAR2L3MBTL1CA12CA1CA2
Hydrochloric Acid SCHEMBL29911081 0.98 HCAR2 (0.43) HCAR2L3MBTL1CA12CA1CA2
SCHEMBL11395654 0.90 HCAR2 (0.42) HCAR2L3MBTL1CA12CA1CA2
SCHEMBL18828565 0.87 HCAR2 (0.52) HCAR2L3MBTL1CA12CA1CA2
SCHEMBL7512242 0.87 HCAR2 (0.52) HCAR2L3MBTL1CA12CA1CA2
SCHEMBL7512241 0.87 HCAR2 (0.52) HCAR2L3MBTL1CA12CA1CA2
SCHEMBL425748 0.84 HCAR2 (0.48) HCAR2L3MBTL1CA12CA1CA2
SCHEMBL1126533 0.84 HCAR2 (0.48) HCAR2L3MBTL1CA12CA1CA2
SCHEMBL1126534 0.84 HCAR2 (0.48) HCAR2L3MBTL1CA12CA1CA2
SCHEMBL425749 0.84 HCAR2 (0.48) HCAR2L3MBTL1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040092737-A1 Benzopiperidine derivatives EISAI CO., LTD. 2004-05-13 US disclosed
US-6518423-B1 These compounds are useful as drugs efficacious in the prevention and treatment of these various inflammatory diseases and immunologic diseases, such as rheumatoid arthritis, atopic dermatitis, psoriasis, asthma, and EISAI CO., LTD. (JP) 2003-02-11 US disclosed
EP-0934941-A1 BENZOPIPERIDINE DERIVATIVES Eisai Co., Ltd. (JP) 1999-08-11 EP disclosed
CN-1036458-C Condensed heterocyclic compouds, their production and use 1997-11-19 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092737-A1 Benzopiperidine derivatives HLA-DRB1, HRH1, HRH2 HCAR2 245/4885L3MBTL1 4411/4885CA12 4489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.